First Manhattan’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$415K Hold
9,044
﹤0.01% 601
2025
Q4
$469K Hold
9,044
﹤0.01% 569
2025
Q3
$385K Hold
9,044
﹤0.01% 587
2025
Q2
$369K Sell
9,044
-1,600
-15% -$65.8K ﹤0.01% 586
2025
Q1
$518K Hold
10,644
﹤0.01% 490
2024
Q4
$468K Hold
10,644
﹤0.01% 513
2024
Q3
$597K Sell
10,644
-800
-7% -$43.6K ﹤0.01% 452
2024
Q2
$585K Sell
11,444
-1,856
-14% -$91.9K ﹤0.01% 442
2024
Q1
$707K Sell
13,300
-950
-7% -$47.7K ﹤0.01% 427
2023
Q4
$651K Sell
14,250
-14,400
-50% -$602K ﹤0.01% 431
2023
Q3
$1.18M Sell
28,650
-1,200
-4% -$52.9K ﹤0.01% 363
2023
Q2
$1.33M Hold
29,850
﹤0.01% 359
2023
Q1
$1.28M Hold
29,850
﹤0.01% 379
2022
Q4
$1.41M Sell
29,850
-2,600
-8% -$118K 0.01% 377
2022
Q3
$1.25M Sell
32,450
-500
-2% -$22K 0.01% 383
2022
Q2
$1.44M Sell
32,950
-3,600
-10% -$165K 0.01% 372
2022
Q1
$1.87M Sell
36,550
-1,200
-3% -$57.8K 0.01% 373
2021
Q4
$2.11M Sell
37,750
-250
-0.7% -$12.7K 0.01% 339
2021
Q3
$1.8M Hold
38,000
0.01% 350
2021
Q2
$1.77M Sell
38,000
-300
-0.8% -$13.1K 0.01% 344
2021
Q1
$1.53M Sell
38,300
-100
-0.3% -$3.95K 0.01% 362
2020
Q4
$1.45M Hold
38,400
0.01% 351
2020
Q3
$1.25M Sell
38,400
-400
-1% -$12.9K 0.01% 362
2020
Q2
$1.14M Hold
38,800
0.01% 371
2020
Q1
$879K Sell
38,800
-400
-1% -$11.5K 0.01% 392
2019
Q4
$1.25M Hold
39,200
0.01% 386
2019
Q3
$962K Sell
39,200
-1,200
-3% -$30.5K 0.01% 418
2019
Q2
$1.06M Sell
40,400
-800
-2% -$19.8K 0.01% 422
2019
Q1
$1.08M Sell
41,200
-600
-1% -$15.1K 0.01% 426
2018
Q4
$950K Hold
41,800
0.01% 446
2018
Q3
$1.21M Sell
41,800
-800
-2% -$21K 0.01% 439
2018
Q2
$962K Sell
42,600
-1,200
-3% -$26.4K 0.01% 449
2018
Q1
$938K Sell
43,800
-800
-2% -$18.6K 0.01% 441
2017
Q4
$983K Hold
44,600
0.01% 450
2017
Q3
$953K Hold
44,600
0.01% 450
2017
Q2
$892K Sell
44,600
-800
-2% -$14.7K 0.01% 450
2017
Q1
$796K Sell
45,400
-4,200
-8% -$70.7K ﹤0.01% 458
2016
Q4
$745K Sell
49,600
-800
-2% -$12.1K ﹤0.01% 452
2016
Q3
$829K Sell
50,400
-2,400
-5% -$40.5K 0.01% 445
2016
Q2
$844K Hold
52,800
0.01% 439
2016
Q1
$755K Hold
52,800
﹤0.01% 446
2015
Q4
$870K Hold
52,800
0.01% 437
2015
Q3
$752K Hold
52,800
﹤0.01% 458
2015
Q2
$982K Sell
52,800
-2,200
-4% -$40.1K 0.01% 432
2015
Q1
$972K Sell
55,000
-4,000
-7% -$67.4K 0.01% 432
2014
Q4
$913K Sell
59,000
-5,200
-8% -$76.6K 0.01% 438
2014
Q3
$864K Sell
64,200
-1,600
-2% -$20.7K 0.01% 446
2014
Q2
$806K Hold
65,800
0.01% 445
2014
Q1
$741K Hold
65,800
﹤0.01% 456
2013
Q4
$667K Sell
65,800
-3,800
-5% -$35.9K ﹤0.01% 476
2013
Q3
$597K Hold
69,600
﹤0.01% 474
2013
Q2
$603K Buy
+69,600
New +$528K ﹤0.01% 475

Other funds holding RXL

First Manhattan's RXL Position: Q1 2026 in Review

First Manhattan held its ProShares Ultra Health Care (RXL) position steady in Q1 2026 at 9,044 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

First Manhattan first reported a position in RXL in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.11M in Q4 2021. 17 funds tracked by Wall St. Rank hold RXL as of Q1 2026.

  • First Manhattan held 9,044 shares of ProShares Ultra Health Care worth $415K as of Q1 2026.
  • First Manhattan left its ProShares Ultra Health Care share count unchanged in Q1 2026.
  • ProShares Ultra Health Care made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #601 holding.
  • First Manhattan first reported a position in ProShares Ultra Health Care in Q2 2013 and has held it in 52 quarters since.
  • First Manhattan's ProShares Ultra Health Care position peaked at $2.11M in Q4 2021.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.